Philip G. Bardin

11.3k total citations · 3 hit papers
163 papers, 6.0k citations indexed

About

Philip G. Bardin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Philip G. Bardin has authored 163 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Pulmonary and Respiratory Medicine, 100 papers in Physiology and 23 papers in Immunology. Recurrent topics in Philip G. Bardin's work include Asthma and respiratory diseases (83 papers), Respiratory and Cough-Related Research (53 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers). Philip G. Bardin is often cited by papers focused on Asthma and respiratory diseases (83 papers), Respiratory and Cough-Related Research (53 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers). Philip G. Bardin collaborates with scholars based in Australia, United Kingdom and United States. Philip G. Bardin's co-authors include Sebastian L. Johnston, Stephen T. Holgate, Belinda J. Thomas, Eric D. Bateman, Stephanie Korn, David J. Fraenkel, Philip Pattemore, Lynette Joubert, Jorge Máspero and Mario Castro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Philip G. Bardin

151 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

2015 840 citations Philip G. Bardin et al. profile →
Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.

1993 459 citations Philip G. Bardin, Stephen T. Holgate et al. profile →
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease

2020 187 citations Saleela M. Ruwanpura, Belinda J. Thomas et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip G. Bardin Australia	41	3.5k	3.0k	1.2k	1.0k	886	163	6.0k
Giovanni A. Rossi Italy	40	2.2k 0.6×	2.6k 0.9×	691 0.6×	1.1k 1.0×	799 0.9×	197	5.4k
Hong Wei Chu United States	43	3.0k 0.9×	2.8k 0.9×	2.0k 1.7×	1.2k 1.1×	532 0.6×	167	6.9k
Attilio Boner Italy	41	3.1k 0.9×	2.6k 0.8×	428 0.3×	653 0.6×	1.5k 1.7×	238	6.1k
Charles McSharry United Kingdom	46	2.4k 0.7×	2.3k 0.7×	2.3k 1.9×	486 0.5×	755 0.9×	128	7.2k
Ken Ohta Japan	42	4.0k 1.1×	2.7k 0.9×	2.2k 1.8×	827 0.8×	1.5k 1.7×	286	7.0k
Martin R. Stämpfli Canada	42	1.8k 0.5×	1.8k 0.6×	1.9k 1.6×	737 0.7×	511 0.6×	135	5.5k
Christian Taube Germany	54	3.9k 1.1×	2.9k 1.0×	3.8k 3.1×	785 0.7×	1.2k 1.4×	353	9.4k
P. Scheinmann France	51	2.6k 0.7×	2.9k 1.0×	703 0.6×	787 0.8×	1.7k 1.9×	285	6.7k
Mark D. Inman Canada	53	5.6k 1.6×	4.0k 1.3×	2.2k 1.8×	434 0.4×	2.0k 2.2×	157	8.9k
Hisamichi Aizawa Japan	42	2.8k 0.8×	3.1k 1.0×	873 0.7×	571 0.5×	424 0.5×	240	6.3k

Countries citing papers authored by Philip G. Bardin

Since Specialization

Citations

This map shows the geographic impact of Philip G. Bardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Bardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Bardin more than expected).

Fields of papers citing papers by Philip G. Bardin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Bardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Bardin. The network helps show where Philip G. Bardin may publish in the future.

Co-authorship network of co-authors of Philip G. Bardin

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Bardin. A scholar is included among the top collaborators of Philip G. Bardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Bardin. Philip G. Bardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Politis, John D., Philip G. Bardin, & Paul Leong. (2024). Contemporary Concise Review 2023: Asthma. Respirology. 29(8). 674–684.

Langton, David, et al.. (2023). Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics. Respirology. 28(12). 1117–1125. 5 indexed citations

MacDonald, Martin, Kevan R. Polkinghorne, Chris MacDonald, et al.. (2023). Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β₂‐agonists. Respirology. 28(9). 860–868. 8 indexed citations

Yap, Grace, et al.. (2023). Vocal cord dysfunction/inducible laryngeal obstruction cannot be diagnosed from symptoms. ERJ Open Research. 9(6). 707–2023. 1 indexed citations

MacDonald, Martin, Christian Osadnik, Paul Leong, et al.. (2021). MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations. ERJ Open Research. 7(3). 198–2021. 11 indexed citations

Blakey, John, Li Ping Chung, Vanessa M. McDonald, et al.. (2021). Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand. Respirology. 26(12). 1112–1130. 54 indexed citations

MacDonald, Martin & Philip G. Bardin. (2021). Contemporary Concise Review 2020: Chronic obstructive pulmonary disease. Respirology. 26(5). 493–500.

Leong, Paul & Philip G. Bardin. (2021). The untreated treatable trait: Cardiovascular disease in COPD exacerbations. Respirology. 26(5). 413–415. 5 indexed citations

Bardin, Philip G. & Sebastian L. Johnston. (2020). Attenuating COVID‐19 infection and inflammation: Lessons from asthma. Respirology. 25(12). 1233–1234. 2 indexed citations

10.

McDonald, Vanessa M., James Fingleton, Àlvar Agustí, et al.. (2019). Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. European Respiratory Journal. 53(5). 1802058–1802058. 199 indexed citations

11.

Bardin, Philip G., et al.. (2018). Swallow and Aspiration in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 198(9). 1122–1129. 24 indexed citations

12.

Pépin, Geneviève, Belinda J. Thomas, Jonathan Ferrand, et al.. (2016). Activation of cGAS-dependent antiviral responses by DNA intercalating agents. Nucleic Acids Research. 45(1). 198–205. 36 indexed citations

13.

Ruwanpura, Saleela M., Louise McLeod, Lovisa Dousha, et al.. (2016). Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema. American Journal of Respiratory and Critical Care Medicine. 194(12). 1494–1505. 39 indexed citations

14.

Low, Kathy A., Kenneth K. Lau, Peter W. Holmes, et al.. (2011). Abnormal Vocal Cord Function in Difficult-to-Treat Asthma. American Journal of Respiratory and Critical Care Medicine. 184(1). 50–56. 100 indexed citations

15.

Ruwanpura, Saleela M., Louise McLeod, Alistair Miller, et al.. (2011). Interleukin-6 Promotes Pulmonary Emphysema Associated with Apoptosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 45(4). 720–730. 62 indexed citations

16.

MacDonald, Martin, Richard Beasley, Louis Irving, & Philip G. Bardin. (2010). A hypothesis to phenotype COPD exacerbations by aetiology. Respirology. 16(2). 264–268. 17 indexed citations

17.

Bardin, Philip G., et al.. (2000). Peak expiratory flow changes during experimental rhinovirus infection. European Respiratory Journal. 16(5). 980–985. 31 indexed citations

18.

Wyser, C, et al.. (1997). Treatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A. American Journal of Respiratory and Critical Care Medicine. 156(5). 1371–1376. 72 indexed citations

19.

Eickelberg, Oliver, C Wyser, Michael Tamm, et al.. (1997). MMP and TIMP Expression Pattern in Pleural Effusions of Different Origins. American Journal of Respiratory and Critical Care Medicine. 156(6). 1987–1992. 49 indexed citations

20.

Bardin, Philip G. & Stephen T. Holgate. (1991). Present and future antiinflammatory strategies for the treatment of asthma. Drugs of today. 27(2). 107–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact